Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings

PURPOSE: To retrospectively compare the clinical manifestation and magnetic resonance (MR) imaging features of liver adenomatosis with pathologic findings. MATERIALS AND METHODS: This study had institutional review board approval, and informed consent was waived. Twenty patients were classified on the basis of pathologic findings into three groups: those with a steatotic, those with a peliotic, and those with a mixed (steatotic and peliotic) form of liver adenomatosis. MR images were reviewed in consensus by two abdominal radiologists, and findings were compared with the pathologic classification. Statistical evaluation was performed with the Student t test. RESULTS: All patients were women (mean age, 39 years +/- 10 [standard deviation]). Lesions of the steatotic form (n = 7) showed (a) a mean diameter of 6.3 cm +/- 1.7, (b) slightly hyperintense signal on T2-weighted images, (c) hyper- or isointense signal on T1-weighted images with a signal dropout with fat suppression sequences, and (d) moderate enhancement at the arterial phase with no delayed enhancement. Lesions of the peliotic form (n = 7) showed (a) a somewhat larger size (8.3 cm +/- 3.6), (b) markedly hyperintense signal on T2-weighted images, (c) iso- or hyperintensity on T1-weighted images with no signal dropout with fat suppression sequences, and (d) strong arterial enhancement and persistent enhancement at the portal and delayed phase. Lesions of the mixed form (n = 6) included a combination of imaging features of the steatotic and peliotic forms. Lesions, however, were significantly larger in the mixed form than in the steatotic form (10.3 cm +/- 4, P < .05). CONCLUSION: There are three patterns of MR imaging features of liver adenomatosis that are associated with three pathologic forms (steatotic, peliotic, and mixed).     

甲状腺乳头状癌的CT表现与病理对照分析

和PTMC病灶,其钙化形式表现不同;与N-PTC比较,乳头状壁结节,增强后强化相对不明显,以及易发生颈部淋巴结转移在PTC更常见.     

Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings

PURPOSE: To retrospectively evaluate computed tomographic (CT) features of pleomorphic carcinoma of the lung and to compare these features with pathologic findings. MATERIALS AND METHODS: Ten patients (10 men, three women; mean age at diagnosis, 64.1 years; range, 43-75 years) with pleomorphic carcinoma treated from June 2000 to January 2003 were selected from two institutions. Two radiologists retrospectively reviewed CT features, which included size and location of tumor, presence of calcification, attenuation values and internal architecture of the mass, and invasion of pleura and chest wall. Attenuation values of the mass on CT scans were compared with pathologic findings in tumors in available gross specimens. Follow-up CT scans were not routinely obtained except in two patients with progressive pleural effusion and rapid growth of the tumor as seen on serial chest radiographs. RESULTS: On unenhanced CT scans, attenuation of the tumor was similar to that of the surrounding muscle. Calcification within the tumor was visible in one patient. Invasion of chest wall was noted in two patients. Seven patients had pleural invasion. Tumors were located at the lung periphery in nine patients. On contrast material-enhanced CT scans, lesions with the longest diameter larger than 5 cm showed central low-attenuation areas with substantial enhancement in the tumor periphery; in comparison, lesions with the longest diameter smaller than 5 cm showed homogeneous enhancement. Size of two lesions with the longest diameter larger than 5 cm increased rapidly after a follow-up of shorter than 3 weeks. Low-attenuation areas on contrast-enhanced CT scans were found to correspond to areas of myxoid degeneration, necrosis, or hemorrhage in pathologic specimens. CONCLUSION: Findings of this study suggest that pleomorphic carcinomas of the lung preferentially manifest as large peripheral lung neoplasms with a central low-attenuation area and frequently invade the pleura and chest wall.     

MR imaging findings of early bile duct cancer

Purpose

To retrospectively evaluate the MR imaging features of early bile duct cancer and to correlate them with the clinicopathologic findings.

Materials and Methods

This retrospective study was approved by our institutional review board, and informed consent was waived. Seventeen patients with surgically proven early bile duct cancer who had undergone preoperative MR cholangiopancreatography with gadolinium‐enhanced MR imaging, were included in this study. Two, experienced radiologists evaluated the MR images in consensus regarding the following findings: tumor number and morphology; signal intensity of the tumor; sharpness of the outer border of the bile duct wall; enhancement pattern of the tumor; and the presence of enlarged peribiliary lymph nodes. Another radiologist measured the SNR of the tumor and bile duct wall on gadolinium‐enhanced MRI during the dynamic phases to evaluate the tumor enhancement degree.

Results

In all patients, MR imaging demonstrated single or multiple intraluminal bile duct masses showing a sharply defined outer margin. The most common enhancement pattern of the biliary lesions showed heterogeneous amorphous enhancement or heterogeneous enhancement with central, dot‐like structures or vascular structures (76.5%, 13/17 patients). The difference of SNR between bile duct and tumor was greatest in the equilibrium phase (P < 0.05).

Conclusion

MRCP combined with dynamic contrast‐enhanced MRI can be useful for detecting early bile duct cancers. Common MR findings of early bile duct cancer include one or more inhomogeneously enhancing intraductal masses with clear outer margins and preservation of the bile duct wall. J. Magn. Reson. Imaging 2008;28:1466–1475. © 2008 Wiley‐Liss, Inc.     

肾嫌色细胞癌的影像表现与病理对照分析

目的分析肾嫌色细胞癌（CCRC）的影像表现特征并与病理结果进行对照，以提高诊断准确性。方法回顾性分析了12例CCRC的资料，其中10例经CT检查，包括平扫、皮质期和髓质期动态增强扫描（1例无皮质期扫描）。2例经MR检查，包括平扫T1WI、T2WI及皮质期和髓质期动态增强T1WI。结果病灶位于左肾4例，右肾8例，最大径24．0～125．0mm，平均56．7mm。10例CT检查中，6例在平扫上密度均匀一致，5例增强后扫描强化均匀一致，与病理上该肿瘤较少发生坏死、囊变、出血对应。皮质期，9个病灶的强化程度均高于髓质，低于皮质，强化程度与微血管密度密切相关；髓质期，10个病灶密度均明显低于髓质。2个体积较大的病灶内见中央星状瘢痕。4个病灶周围见假包膜。MR检查的2例相对于髓质，病灶在平扫T1WI上呈高信号，在T2WI上，表现为明显的低信号。病灶的强化方式与CT相似。结论CCRC在CT及MRI上的均质性特点、独特的强化方式及T1WI上呈相对于髓质的明显低信号，具有一定的特征性，有助于与其他肿瘤鉴别。     

Hepatocellular carcinoma with bile duct tumor thrombi: Correlation of magnetic resonance imaging features to histopathologic manifestations

Purpose

This study was to analyze the magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) with bile duct tumor thrombi, and explore their correlations to histopathology to improve the accuracy of diagnosis.

Materials and methods

21 patients with pathologically confirmed HCC with bile duct tumor thrombi was performed with a superconducting 1.5-T MR imager within two weeks before operation. Magnetic resonance cholangiopancreatography (MRCP) was performed on 18 patients. Images were retrospectively assessed for the size, location and MRI manifestations of HCC lesions and associated bile duct tumor thrombi. The differentiation of HCC lesions and the pathologic changes of bile duct tumor thrombi were retrospectively analyzed under microscope.

Results

The average diameter of HCC lesions was 5.8 ± 2.8 cm, and ≤5.0 cm in nine cases. Capsule formation was observed on MRI or pathology in 4 cases of HCC (19%). Of the 21 cases with bile duct tumor thrombi, 20 were clearly presented on MRI as cord-like or columnar masses in the bile duct with proximal cholangiectasis. The tumor thrombi showed slightly hypointense on T1WI and slightly hyperintense on T2WI. On enhanced scan, three cases of tumor thrombi, which were mainly consisted of necrotic tissue, did not show enhancement; 17 cases, which were mainly consisted of cancer cells, showed mild or moderate enhancement. On magnetic resonance cholangiopancreatogram (MRCP), 14 cases of tumor thrombi presented as filling defect in the bile duct, abrupt obstruction of the bile duct, and cholangiectasis above the obstruction; four presented as dilated intra-hepatic bile ducts with missing common bile duct. Of the 21 patients, 16 had biliary hemorrhage; three also had tumor thrombi in the portal vein. Seventeen of the 21 HCC with biliary thrombi were poorly differentiated, unencapsulated and with an invasive growth. Nineteen of 21 bile duct tumor thrombi did not invade the bile duct wall and could be easily extracted.

Conclusion

MRI plays a valuable role in diagnosing HCC with bile duct tumor thrombi and identifying the extent of the thrombi; the MRI features of HCC with bile duct tumor thrombi are associated with its pathologic changes.     

MR imaging of uterine carcinoma: correlation with clinical and pathologic findings

Thirteen patients with clinical stages I and II endometrial carcinoma were examined with magnetic resonance (MR) imaging before surgery. Depth of invasion and stage of disease were assessed, and the results were compared with those from MR images of the surgical specimens and pathologic findings. Staging with MR imaging was accurate in 11 of 13 patients (85%). Our results agree with previous reports that MR imaging is an accurate, noninvasive method of assessing depth of myometrial invasion and cervical involvement. We anticipate that MR imaging will have an increasing role in treatment of patients with endometrial carcinoma.     

Peripheral T-cell lymphoma: spectrum of imaging findings with clinical and pathologic features.

Most radiologists are unfamiliar with peripheral T-cell lymphoma (PTCL) because PTCL represents a relatively small proportion of lymphomas and has a lower prevalence in Western countries. The World Health Organization classification of lymphoid neoplasms announced in 1999 resolved criticisms about lymphoma classification and aroused new interest in PTCL. The specific clinicopathologic entities of PTCL have particular primary locations and particular clinical and pathologic features. Radiologic images of patients with pathologically proved PTCL were retrospectively reviewed; clinical and pathologic data were also reviewed. PTCL involves various organs including the sinonasal cavity, airway, intestinal tract, skin, lymph nodes, liver, lung, and musculoskeletal system. The pattern of disease involvement in PTCL is not random. There is a correlation between specific clinicopathologic entities and the primary site of involvement, although the findings in the disseminated stage of disease do not allow differential diagnosis. It is significant that the radiologic features or locations of several entities are different from those of lymphoma with the B-cell phenotype. Radiologic demonstration of disease progression beyond the primary site is clinically important because systemic dissemination in most of the entities leads to a dramatic change in the prognosis. Copyright RSNA, 2003.     

Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcome

Objective

The purpose of our study was to describe the clinical features, imaging characteristics, pathologic findings and outcome of microinvasive ductal carcinoma in situ (DCISM).

Materials and methods

The records of 21 women diagnosed with microinvasive ductal carcinoma in situ (DCISM) from November 1993 to September 2006 were retrospectively reviewed. The clinical presentation, imaging and histopathologic features, and clinical follow-up were reviewed.

Results

The 21 lesions all occurred in women with a mean age of 56 years (range, 27-79 years). Clinical findings were present in ten (48%): 10 with palpable masses, four with associated nipple discharge. Mean lesion size was 21 mm (range, 9-65 mm). The lesion size in 62% was 15 mm or smaller. Mammographic findings were calcifications only in nine (43%) and an associated or other finding in nine (43%) [mass (n = 7), asymmetry (n = 1), architectural distortion (n = 1)]. Three lesions were mammographically occult. Sonographic findings available in 11 lesions showed a solid hypoechoic mass in 10 cases (eight irregular in shape, one round, one oval). One lesion was not seen on sonography. On histopathologic examination, all lesions were diagnosed as DCISM, with a focus of invasive carcinoma less than or equal to 1 mm in diameter within an area of DCIS. Sixteen (76%) lesions were high nuclear grade, four (19%) were intermediate and one was low grade (5%). Sixteen (76%) had the presence of necrosis. Positivity for ER and PR was noted in 75% and 38%. Nodal metastasis was present in one case with axillary lymph node dissection. Mean follow-up time for 16 women was 36 months without evidence of local or systemic recurrence. One patient developed a second primary in the contralateral breast 3 years later.

Conclusion

The clinical presentation and radiologic appearance of a mass are commonly encountered in DCISM lesions (48% and 57%, respectively), irrespective of lesion size, mimicking findings seen in invasive carcinoma. Despite its potential for nodal metastasis (5% in our series), mean follow-up at 36 months was good with no evidence of local or systemic recurrence at follow-up. Knowledge of these clinical and imaging findings in DCISM lesions may alert the clinician to the possibility of microinvasion and guide appropriate management.     

肝脏局灶性结节增生的典型与非典型MR表现及其病理基础

目的:研究肝脏局灶性结节增生(FNH)的典型与非典型MR表现及其病理基础,探讨MRI对各型的诊断价值。方法:分析经手术病理证实的FNH 28例(36个病灶)的典型与非典型MR表现,并与病理结果相对照。结果:①典型表现20例(28个病灶),大小在2.0~10.5cm,T1WI上呈等/稍低信号,T2WI上呈等/稍高信号,增强扫描动、门脉期病变呈显著增强,延迟扫描呈等/略高信号,中心瘢痕出现率占42.9%(12/28例),于T1WI上呈低信号,T2WI上呈高信号,增强扫描呈延迟强化。组织学上有特征性的中央纤维瘢痕,由纤维结缔组织和扭曲的血管组成,并向外放射状形成许多纤维间隔,纤维间隔旁围绕以无明显异形性的肝细胞形成硬化样结节;②非典型表现8例(8个病灶),大小在1.5~8.5cm,T1WI呈略高或低信号,T2WI呈不均匀高信号,增强扫描病灶强化不显著、不均匀,病灶内未见中心瘢痕或瘢痕不强化,出现假包膜等。镜下病变内毛细胆管扩张,其内纤维分隔较短、不连续,部分较大病灶内有出血、脂肪变及坏死,但无异型性肝细胞。结论:MRI能很好反映肝脏局灶性结节增生的典型与非典型表现的病理基础,具有高度的诊断特异性。     

肾上腺外节细胞神经瘤的CT表现与病理对照分析

目的 探讨肾上腺外节细胞神经瘤的CT特征,以提高对该病的认识和诊断水平.方法 回顾分析13例经手术、病理证实的肾上腺外节细胞神经瘤的CT表现,并与病理结果进行对照.结果 13例肾上腺外节细胞神经瘤2例位于颈部,4例位于后纵隔,4例位于腹膜后,2例位于骶前,1例位于肾门区.肿块边界清晰,2例病灶呈圆形,3例呈类圆形,8例呈不规则形.不规则形中,6例呈塑形生长,包绕或推移周围血管,但血管形态正常,无侵犯征象;2例侵及椎间孔.CT平扫肿块密度低于肌肉,密度均匀4例,密度不均匀9例,其中2例病灶内见点状钙化.增强后5例病灶无强化,8例病灶动脉期轻度强化,静脉期及延迟期轻至中度持续强化.镜下示:肿瘤含大量黏液基质,其间散在成熟的神经纤维细胞、胞浆丰富的节细胞和梭形的Schwann细胞.结论 肾上腺外节细胞神经瘤的CT表现具有一定特征性,与病理特点有很好的相关性,有助于诊断和鉴别诊断.     

小儿外周性节细胞神经瘤的影像表现与病理对照分析

目的:分析小儿外周性节细胞神经瘤的影像表现特征,以提高诊断准确性。方法:回顾性分析24例小儿外周性节细胞神经瘤影像学资料,并与病理结果进行对照。术前19例CT平扫与增强,7例MRI平扫与增强,其中2例同时做了CT和MRI检查。结果:24例外周性节细胞神经瘤中位于腹膜后10例,肾上腺8例,后纵隔5例,颈部1例。均为单发病灶,边界清楚,圆形或类圆形22例,不规则形2例。病灶平均直径7.9cm,CT平扫为均匀或不均匀低密度,4例肿瘤内出现点状或条状钙化。增强后轻度强化或不均匀条片状强化,4例延迟后进行性增强。T1WI表现为均匀或不均匀低信号,T2WI表现为均匀或不均匀高信号,其中1例内见曲线形低信号灶。强化方式与CT相似。肿瘤推移和包绕血管但不侵犯血管。结论:CT和MRI平扫及增强扫描能较好地显示节细胞神经瘤的内部结构和影像学特点,反映病灶的病理特征,有助于与其它病变的鉴别。